Molecular detection methods and serotyping performed directly on clinical samples improve diagnostic sensitivity and reveal increased incidence of invasive disease by in Italian children Free

Abstract

The aims of this study were to evaluate the incidence of invasive pneumococcal disease (IPD) in Italian children and perform serotyping by PCR-based assays directly on clinical samples. A 1-year paediatric (0–14 years) population-based surveillance study was designed to evaluate the incidence of IPD in the province of Florence, Italy, by cultural and molecular methods. Among 92 children (80 with pneumonia, 8 with meningitis/sepsis, 4 with arthritis), 4 cases of IPD were diagnosed both by culture and real-time PCR and 18 cases exclusively by molecular methods. The sensitivity of molecular methods was significantly higher than that of cultural methods (Cohen’s 0.41; McNemar =0.000008). The incidence of IPD in children below 2 years of age was 11.5/100 000 and 51.8/100 000 by cultural and molecular methods, respectively. Pneumococcal serotyping by multiplex sequential PCR was obtained in 19/22 samples. Real-time PCR and multiplex sequential PCR can be used directly on biological samples, improving the ability to diagnose IPD. The incidence of IPD appears 5–10 times higher by PCR than by cultural methods.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.2008/000935-0
2008-10-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jmm/57/10/1205.html?itemId=/content/journal/jmm/10.1099/jmm.0.2008/000935-0&mimeType=html&fmt=ahah

References

  1. Arbique J. C., Poyart C., Trieu-Cuot P., Quesne G., Carvalho Mda. G., Steigerwalt A. G., Morey R. E., Jackson D., Davidson R. J., Facklam R. R. 2004; Accuracy of phenotypic and genotypic testing for identification of Streptococcus pneumoniae and description of Streptococcus pseudopneumoniae sp. nov. J Clin Microbiol 42:4686–4696 [CrossRef]
    [Google Scholar]
  2. Black S., Shinefield H., Baxter R., Austrian R., Bracken L., Hansen J., Lewis E., Fireman B. 2004; Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente. Pediatr Infect Dis J 23:485–489 [CrossRef]
    [Google Scholar]
  3. Black S., Shinefield H., Eskola J., Whitney C. 2007; Pneumococcal conjugate vaccine. In Vaccines , V edn, chapter 23. Edited by Plotkin S. A., Orenstein W. A., Offit P. Philadelphia, PA: WB Saunders;
    [Google Scholar]
  4. Carvalho Mda. G., Tondella L., McCaustland K., Weidlich L., McGee L., Mayer L. W., Steigerwalt A., Whaley M., Facklam R. R. other authors 2007; Evaluation and improvement of real-time PCR assays targeting lyt , ply , and psaA genes for detection of pneumococcal DNA. J Clin Microbiol 45:2460–2466 [CrossRef]
    [Google Scholar]
  5. CDC 1997; Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 46:1–24
    [Google Scholar]
  6. Clarke S. C. 2006; Detection of Neisseria meningitidis , Streptococcus pneumoniae , and Haemophilus influenzae in blood and cerebrospinal fluid using fluorescence-based PCR. Methods Mol Biol 345:69–77
    [Google Scholar]
  7. Corless C. E., Guiver M., Borrow R., Edwards-Jones V., Fox A. J., Kaczmarski E. B. 2001; Simultaneous detection of Neisseria meningitidis , Haemophilus influenzae , and Streptococcus pneumoniae in suspected cases of meningitis and septicemia using real-time PCR. J Clin Microbiol 39:1553–1558 [CrossRef]
    [Google Scholar]
  8. Dalton H. P., Allison M. J. 1968; Modification of laboratory results by partial treatment of bacterial meningitis. Am J Clin Pathol 49:410–413
    [Google Scholar]
  9. D'Ancona F., Salmaso S., Barale A., Boccia D., Lopalco P. L., Rizzo C., Monaco M., Massari M., Demicheli V. other authors 2005; Incidence of vaccine preventable pneumococcal invasive infections and blood culture practices in Italy. Vaccine 23:2494–2500 [CrossRef]
    [Google Scholar]
  10. Domínguez A., Salleras L., Cardeñosa N., Ciruela P., Carmona G., Martínez A., Torner N., Fuentes M. 2002; The epidemiology of invasive Streptococcus pneumoniae disease in Catalonia (Spain). A hospital-based study. Vaccine 20:2989–2994 [CrossRef]
    [Google Scholar]
  11. Esposito S., Bosis S., Colombo R., Carlucci P., Faelli N., Fossali E., Principi N. 2004; Evaluation of rapid assay for detection of Streptococcus pneumoniae urinary antigen among infants and young children with possibile invasive pneumococcal disease. Pediatr Infect Dis J 23:365–367 [CrossRef]
    [Google Scholar]
  12. Gendrel D., Raymond J., Moulin F., Iniguez J. L., Ravilly S., Habib F., Lebon P., Kalifa G. 1997; Etiology and response to antibiotic therapy of community-acquired pneumonia in French children. Eur J Clin Microbiol Infect Dis 16:388–391 [CrossRef]
    [Google Scholar]
  13. Hausdorff W. P., Bryant J., Paradiso P. R., Siber G. R. 2000; Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin Infect Dis 30:100–121 [CrossRef]
    [Google Scholar]
  14. Juvén T., Mertsola J., Waris M., Leinonen M., Meurman O., Roivainen M., Eskola J., Saikku P., Ruuskanen O. 2000; Etiology of community-acquired pneumonia in 254 hospitalized children. Pediatr Infect Dis J 19:293–298 [CrossRef]
    [Google Scholar]
  15. Kaczmarski E. B. 1997; Meningococcal disease in England and Wales: 1995. Commun Dis Rep CDR Rev 7:R55–R59
    [Google Scholar]
  16. Kaltoft H., Zeuthen N., Konradsen H. B. 2000; Epidemiology of invasive pneumococcal infections in children aged 0–6 years in Denmark: a 19-year nationwide surveillance study. Acta Paediatr Suppl 89:3–10 [CrossRef]
    [Google Scholar]
  17. Kaplan S. L. 2005; Osteomyelitis in children. Infect Dis Clin North Am 19:787–797 [CrossRef]
    [Google Scholar]
  18. Kaplan S. L., Mason E. O. Jr, Wald E. R., Schutze G. E., Bradley J. S., Tan T. Q., Hoffman J. A., Givner L. B., Yogev R., Barson W. J. 2004; Decrease of invasive pneumococcal infections in children among 8 children’s hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine. Pediatrics 113:443–449 [CrossRef]
    [Google Scholar]
  19. Kong F., Brown M., Sabananthan A., Zeng X., Gilbert G. L. 2006; Multiplex PCR-based reverse line blot hybridization assay to identify 23 Streptococcus pneumoniae polysaccharide vaccine serotypes. J Clin Microbiol 44:1887–1891 [CrossRef]
    [Google Scholar]
  20. Lahti E., Mertsola J., Kontiokari T., Eerola E., Ruuskanen O., Jalava J. 2006; Pneumolysin polymerase chain reaction for diagnosis of pneumococcal pneumonia and empyema in children. Eur J Clin Microbiol Infect Dis 25:783–789 [CrossRef]
    [Google Scholar]
  21. McAvin J. C., Reilly P. A., Roudabush R. M., Barnes W. J., Salmen A., Jackson G. W., Beninga K. K., Astorga A., McCleskey F. K. other authors 2001; Sensitive and specific method for rapid identification of Streptococcus pneumoniae using real-time fluorescence PCR. J Clin Microbiol 39:3446–3451 [CrossRef]
    [Google Scholar]
  22. Morrison K. E., Lake D., Crook J., Carlone G. M., Ades E., Facklam R., Sampson J. S. 2000; Confirmation of psaA in all 90 serotypes of Streptococcus pneumoniae by PCR and potential of this assay for identification and diagnosis. J Clin Microbiol 38:434–437
    [Google Scholar]
  23. O’Halloran D. M., Cafferkey M. T. 2005; Multiplex PCR for identification of seven Streptococcus pneumoniae serotypes targeted by a 7-valent conjugate vaccine. J Clin Microbiol 43:3487–3490 [CrossRef]
    [Google Scholar]
  24. Ostapchuk M., Roberts D. M., Haddy R. 2004; Community-acquired pneumonia in infants and children. Am Fam Physician 70:899–908
    [Google Scholar]
  25. Overturf G. D. 2005; Defining bacterial meningitis and other infections of the central nervous system. Pediatr Crit Care Med 6:S14–S18 [CrossRef]
    [Google Scholar]
  26. Pai R., Limor J., Beall B. 2005; Use of pyrosequencing to differentiate Streptococcus pneumoniae serotypes 6A and 6B. J Clin Microbiol 43:4820–4822 [CrossRef]
    [Google Scholar]
  27. Pai R., Gertz R. E., Beall B. 2006; Sequential multiplex PCR approach for determining capsular serotypes of Streptococcus pneumoniae isolates. J Clin Microbiol 44:124–131 [CrossRef]
    [Google Scholar]
  28. Pebody R. G., Hellenbrand W., D’Ancona F., Ruutu P. European Union funded Pnc-EURO contributing group; 2006; Pneumococcal disease surveillance in Europe. Euro Surveill 11:171–178
    [Google Scholar]
  29. Rodríguez-Créixems M., Bertó J., Muñoz P., Alonso R., Alcalá L., Bouza E. 2003; Increased incidence of pneumococcal bloodstream infections. Pediatr Infect Dis J 22:661–663
    [Google Scholar]
  30. Russell J. A. 2006; Management of sepsis. N Engl J Med 355:1699–1713 [CrossRef]
    [Google Scholar]
  31. Smith M. D., Stuart J., Andrews N. J., Telfer Brunton W. A., Cartwright K. A. 1998; Invasive pneumococcal infection in South and West England. Epidemiol Infect 120:117–123 [CrossRef]
    [Google Scholar]
  32. Vakevainen M., Eklund C., Eskola J., Kayhty H. 2001; Cross-reactivity of antibodies to type 6B and 6A polysaccharides of Streptococcus pneumoniae , evoked by pneumococcal conjugate vaccines, in infants. J Infect Dis 184:789–793 [CrossRef]
    [Google Scholar]
  33. Van Gastel E., Bruynseels P., Verstrepen W., Mertens A. 2007; Evaluation of a real-time polymerase chain reaction assay for the diagnosis of pneumococcal and meningococcal meningitis in a tertiary care hospital. Eur J Clin Microbiol Infect Dis 26:651–653 [CrossRef]
    [Google Scholar]
  34. Verhelst R., Kaijalainen T., De Baere T., Verschraegen G., Claeys G., Van Simaey L., De Ganck C., Vaneechoutte M. 2003; Comparison of five genotypic techniques for identification of optochin-resistant pneumococcus-like isolates. J Clin Microbiol 41:3521–3525 [CrossRef]
    [Google Scholar]
  35. von Kries R., Siedler A., Schmitt H. J., Reinert R. R. 2000; Proportion of invasive pneumococcal infections in German children preventable by pneumococcal conjugate vaccines. Clin Infect Dis 31:482–487 [CrossRef]
    [Google Scholar]
  36. Whitney C. G., Farley M. M., Hadler J., Harrison L. H., Bennett N. M., Lynfield R., Reingold A., Cieslak P. R., Pilishvili T. other authors 2003; Active Bacterial Core Surveillance of the Emerging Infections Program Network. Decline in invasive pneumococcal disease after the introduction of protein polysaccharide conjugate vaccine. N Engl J Med 348:1737–1746 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.2008/000935-0
Loading
/content/journal/jmm/10.1099/jmm.0.2008/000935-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed